E’ pleonastico affermare che la Medicina è Serva dell’Economia e che l’attuale uso delle staminali è un pericolo grave, evitabile ricorrendo alla Semeiotica Biofisica Quantistica!
Quando nel 2009 scrissi una Lettera Aperta all’allora Ministro Mussi, non ottenni risposta “more solito” : Stagnaro Sergio. Lettera Aperta all’On. Fabio Mussi, Ministro dell’Università e della Ricerca, su Cellule Staminali e Terreno Oncologico. 13 marzo 2009, http://www.fceonline.it/ , http://www.fcenews.it/docs/staminali.pdf
Chiaramente, i nostri governati di ieri ed oggi non così sono sensibili agli argomenti scientifici-critici, come dimostrano di essere a quelli economici.
Di seguito è riferito un mio recente Comment ad un articolo apparso nel sito della CBSNews in cui si parla della possibile terapia con staminali in “alcuni” tipi di tumori.
by SergioStagnaro May 14, 2012 7:31 AM EDT
I find the paper really intriguing and fascinating. However, we must pay attention to following overlooked remarks, I emphasised formerly,for instance, April 12, 2007 at URL http://www.washingtonpost.com/ac2/wpdyn/comments/display?contentID=AR2007041101736&start=41 and June 12, 2011, http://blogs.nature.com/news/2011/06/researchers_rebut_critiques_of.html#comments
In my opinion, a great lot of money on studying stem cells, accounts for the reason there is an overlooked bias in such as research articles! In fact, in performing stem cell researches all around the world scientists continue to overlook both an inherited mithocondrial cytopathy, I termed Congenital Acidosic Enzyme-Metabolic Histangiopathy and Biophysical-Semeiotic Constitutions (1-6). Accordingly,e.g., type 2 diabetes mellitus is a major problem worldwide, a real epidemic. Independent of different countries, in last decades type 2 DM prevalence has increased rapidly over time among both developed and developing populations: in 2030, diabetics will be 360 millions. Surely, genetic factors alone cannot explain these patterns. However, as allows me to state my clinical 55-year-long clinical experience, individuals, without diabetic AND dyslipidemic quantum-biophysical-semeiotic constitutions, can not be involved by type 2 diabets mellitus (1-6). Certainly, rapid changes in lifestyle and risk factors such as obesity, unhealthy diets, physical inactivity, tobacco smoking, a.s.o., acting on people with diabetic and dyslipidaemic constitution may prompt, AT FIRST, Pre-Metabolic Syndrome, then, over years or decades, metabolic syndrome (2, 6), IGT, and finally type 2 diabetes. In a few words, all around the world, e.g., the war against diabetes mellitus and its well-known and harmful so-called complications, as well as the war against all other serious and common human diseases, as cancer and CAD, is nowadays possible, also utilizing possibly stem cells of whatever origin, exclusively by means of a primary prevention, which must be perform at the bed-side, clinically, on a very large scale, using the simple stethoscope. In addition, we must in the future utilize stem cell, of whatever origin, of individuals not involved by above-cited quantum-biophysical-semeiotic constitutions! In other words, in both primary prevention and screening programme for every disease, including type 2 DM, and cancer, we need efficacious clinical tools to obtain the best results, avoiding, e.g., to use stem cell with heritable impaired mitochondria. Really, early diagnosis must certainly be established in asymptomatic patients, who, for example, are evolving slowly towards diabetes mellitus, i.e. long time before disease onset, in order to avoid the well known, severe complications. In fact, to prevent these diabetic “complications”, including diabetic retinopathy, on very large scale it is extremely necessary that doctors use a clinical tool reliable in diagnosing early diabetes mellitus stages, from initial stages, i.e., biophysical-semeiotic constitutions, and then the Pre-Metabolic Syndrome, useful particularly in selecting appropriate stem cells to be utilized. As I wrote formerly in PLOS (7), physicians can fortunately utilize bedside clinical methods reliable in ascertain the truth of articles published in famous peer reviews.
1 Stagnaro S., Stagnaro-Neri M. Valutazione percusso-ascoltatoria del Diabete Mellito. Aspetti teorici e pratici. Epat. 32, 131 1986
2 Stagnaro Sergio, Stagnaro-Neri Marina. Introduzione alla Semeiotica Biofisica. Il Terreno oncologico. Travel Factory SRL., Roma, 2004
3 Stagnaro S., Stagnaro-Neri M., Le Costituzioni Semeiotico-Biofisiche.Strumento clinico fondamentale per la prevenzione primaria e la definizione della Single Patient Based Medicine. Ediz. Travel Factory, Roma, 2004.
4 Stagnaro S., Istangiopatia Congenita Acidosica Enzimo-Metabolica. Una Patologia Mitocondriale Ignorata. Gazz Med. It. – Arch. Sci. Med. 144, 423,1985 Infotrieve.
5 Stagnaro S. Diet and Risk of Type 2 Diabetes. N Engl J Med. 2002 Jan 243464:297-298. [MEDLINE].
6 Stagnaro S.-Neri M..Stagnaro S., Sindrome di Reaven, classica e variante, in evoluzione diabetica. Il ruolo della Carnitina nella prevenzione del diabetemellito. Il Cuore. 6, 617, 1993, [MEDLINE].
7)Stagnaro Sergio. Single Patient Based Medicine: its paramount role in Future Medicine. Public Library of Science. http://medicine.plosjournals.org/perlserv/?request=read-response